Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study

BACKGROUND: Antipsychotic-induced metabolic adverse effects are risk factors for cardiometabolic comorbidities. Whether dose lowering could mitigate such effects remains unclear. The present study aims to investigate the associations between clozapine doses and modifications of weight, blood pressur...

Descripción completa

Detalles Bibliográficos
Autores principales: Piras, Marianna, Chahma, Jihane, Ranjbar, Setareh, Laaboub, Nermine, Grosu, Claire, Plessen, Kerstin Jessica, von Gunten, Armin, Conus, Philippe, Eap, Chin Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318871/
https://www.ncbi.nlm.nih.gov/pubmed/36841954
http://dx.doi.org/10.1093/schbul/sbad009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318871/
https://www.ncbi.nlm.nih.gov/pubmed/36841954
http://dx.doi.org/10.1093/schbul/sbad009

Ejemplares similares